Long Ideas - Shares of Questcor Pharmaceuticals (NASDAQ:QCOR), despite a large short interest, have continued to perform well for shareholders and broke through several resistance levels this week to … Continue Reading
Read now- Another cancer vaccine fell by the wayside on Wednesday morning, as Oncothyreon (NASDAQ:ONTY) and Merck Serono (NYSE:MRK) announced that a Phase III study for the … Continue Reading
Read nowLong Ideas - Pacira Pharmaceuticals (NASDAQ:PCRX) reported on Tuesday morning that, based on the results of a regional health system analysis conducted by Barnabas Health, opioid use in … Continue Reading
Read nowLong Ideas - Orexigen Therapeutics (OREX) will be the last of three leading weight-loss drug developers to enter the large potential market for new obesity treatments, and biotech … Continue Reading
Read nowQuick Picks - A Citizen Petition that Jazz Pharmaceuticals (JAZZ) filed with the FDA in July of 2012 has been rejected, says the company, negating one more barrier … Continue Reading
Read nowLong Ideas - ArQule (NASDAQ:ARQL) has enrolled the first patient in its Phase I trial of the FGFR Inhibitor ARQ-087, the last of five oncology products that the … Continue Reading
Read nowLong Ideas - Acadia Pharmaceuticals (NASDAQ:ACAD) announced on Wednesday morning a private equity financing to sell 19 million shares of common stock at $4.43 per share, plus warrants to purchase … Continue Reading
Read now